OmniVision: March 2026 Share Update Shows Stable H-Share Base, Minor A-Share Uptick from Options; Public Float at 4.02% Worth HK$5.37 Billion

Bulletin Express
04/08

OmniVision Integrated Circuits Group, Inc. released its Monthly Return for Equity Issuer for the period ended 31 March 2026, outlining modest changes in registered capital and confirming compliance with Hong Kong’s public-float requirements. Key takeaways are as follows:

1. Authorised and Issued Share Capital • Registered share capital totalled RMB 1.26 billion (1,261.07 million shares at RMB 1 par value), unchanged month-on-month. • H-share quota remained flat at 50.74 million shares, while A-share authorisations increased marginally by 23,598 shares to 1.21 billion.

2. Share Issuance and Treasury Position • Issued H shares were unchanged at 50.74 million; no treasury H shares are outstanding. • Issued A shares rose by 23,598 to 1.20641 billion, reflecting option exercises. Treasury stock was steady at 3.92 million A shares.

3. Equity Incentive Activity • Two tranches of the 2023 stock-option plans added 23,598 new A shares during the month, generating RMB 1.84 million in proceeds. • Outstanding unexercised options under all incentive schemes total 28.91 million A shares, split across: – 2023 First Phase: 3.37 million options at RMB 78.01 exercise price – 2023 Second Phase: 5.55 million options at RMB 78.01 – 2025 Plan: 19.98 million options at RMB 138.67

4. Convertible Bonds • Convertible bonds due 27 December 2026 remain unchanged at RMB 2.43 billion, carrying a conversion price of RMB 159.12 per share and potentially issuable into 15.29 million A shares; no conversions occurred in March.

5. Public Float Confirmation • The company affirmed compliance with Main Board Rule 13.32D(1). H-share public float stood at 4.02%, equivalent to HK$5.37 billion in market value—well above the HK$1 billion threshold required for PRC issuers with additional listings.

The filing, submitted on 8 April 2026 by Joint Company Secretary Ren Bing, reports no share buy-backs, warrant activity, or HDR movements during the month. Overall, OmniVision’s capital structure remained broadly stable, with incremental dilution limited to option conversions.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10